UCB strikes new Middle East and African sales deal for key products – PMLiVE

by admin on November 22, 2012

UCB strikes new Middle East and African sales deal for key products
PMLiVE
The deal covers the Belgium biopharmaceutical firm's Cimzia (certolizumab pegol) for Crohn's disease and rheumatoid arthritis, Vimpat (lacosamide) for epilepsy and Neupro (rotigotine) for Parkinson's disease and restless legs syndrome. The three drugs

View full post on restless leg syndrome – Google News

Leave a Comment

Previous post:

Next post: